{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-255170","form_type":"8-K","ticker":"HOWL","cik":"0001785530","company_name":"Werewolf Therapeutics, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.622132+00:00","generated_at":"2026-05-30T02:05:40.024305+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"Werewolf Therapeutics posts updated corporate presentation with no disclosed material changes","bullets":["Company made an updated corporate presentation available on its website on November 12, 2024.","Presentation furnished as Exhibit 99.1; no specific financial or operational updates detailed in the filing.","No new financial guidance, clinical data, or corporate developments disclosed in the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-255170","json":"https://secwatch.observer/filing/0001193125-24-255170.json","markdown":"https://secwatch.observer/filing/0001193125-24-255170.md","text":"https://secwatch.observer/filing/0001193125-24-255170.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785530/000119312524255170/0001193125-24-255170-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785530/000119312524255170/d794017d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:05:40.024305+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}